Tewari KS, Sill MW, Coleman RL, Aghajanian C, et al. Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study. Gynecol Oncol 2020 Jul 25. pii: S0090-8258(20)32390.
PMID: 32723679